This novel mechanism not only uncovers a molecular mechanism by which Prrx1 is activated in cardiac fibroblasts, but also provides a novel target for exploring new drugs to improve the prognosis of ischemic heart disease. This evidence concerns the gene PRRX1 and coronary artery disorder.